<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 31, 2000
MedQuist Inc.
---------------------------------------------------------
(Exact name of registrant as specified in its charter)
New Jersey 0-19941 22-253 1298
- ------------------ -------------- -----------
(State or other (Commission File (I.R.S. Employer
jurisdiction Number) Identification No.)
of incorporation
or organization)
Five Greentree Centre
Suite 311
Marlton, NJ 08053
---------------------------------------------------
(address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (609) 596-8877
<PAGE>
Item 5 - Other Events
On January 31, 2000, the registrant issued a press release announcing
that its board of directors has authorized the repurchase of up to 1.5 million
shares of its common stock. The stock will be repurchased in the open market or
in other transactions pursuant to SEC Rule 10b-18. The timing of repurchases and
number of shares actually purchased will depend on a variety of factors,
including price and market conditions.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDQUIST INC.
Date: February 2, 2000 By:
---------------------------
Name: John M. Suender
Title: Senior Vice President and
General Counsel
